Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseBone MarrowHistocompatibilityBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationAnemia, AplasticTransplantation ConditioningTransplantation, AutologousLeukemiaSurvival AnalysisHematopoietic Stem Cell TransplantationBone and BonesHematopoietic Stem CellsGraft RejectionHLA AntigensLeukocyte TransfusionRadiation ChimeraTransplantation, IsogeneicMice, Inbred C57BLLiver TransplantationGraft Enhancement, ImmunologicImmunosuppressionTransplantation ToleranceBone Marrow PurgingRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKidney TransplantationImmunosuppressive AgentsBone Marrow DiseasesBusulfanTreatment OutcomeTime FactorsSkin TransplantationT-LymphocytesTransplantation ImmunologyLymphocyte DepletionGraft vs Host ReactionAcute DiseaseChimerismBone Marrow ExaminationCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisActuarial AnalysisHeart TransplantationLiving DonorsHematologic NeoplasmsTissue and Organ ProcurementBone Marrow NeoplasmsBlood DonorsCombined Modality TherapyLeukemia, Myeloid, AcuteMice, Inbred BALB CRemission InductionLymphocyte Culture Test, MixedChimeraDisease-Free SurvivalHepatic Veno-Occlusive DiseaseLeukemia, MyeloidRetrospective StudiesColony-Forming Units AssayBone RemodelingImmune ToleranceStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionMyelodysplastic SyndromesCord Blood Stem Cell TransplantationSevere Combined ImmunodeficiencyFlow CytometrySpleenCell DifferentiationSurvival RateMice, Inbred C3HHematologic DiseasesLung TransplantationCyclosporineCells, CulturedPancytopeniaLeukocyte CountBone DensityAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyOrgan TransplantationGranulocyte Colony-Stimulating FactorCarmustineFollow-Up StudiesGraft vs Tumor EffectCytomegalovirus InfectionsCytarabineMice, KnockoutMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34